首页|血清可溶性fms样酪氨酸激酶-1/胎盘生长因子和25-羟维生素D3预测子痫前期的价值

血清可溶性fms样酪氨酸激酶-1/胎盘生长因子和25-羟维生素D3预测子痫前期的价值

扫码查看
目的 观察子痫前期孕妇血清可溶性fms样酪氨酸激酶-1(sFlt-1)/胎盘生长因子(PLGF)和25-羟维生素D3[25(OH)D3]水平变化,探讨其预测子痫前期的价值。方法 2020年1月—2022年9月安徽医科大学附属妇幼保健院定期产检并分娩的子痫前期孕妇60例为子痫前期组,无妊娠并发症及合并症的正常孕妇248例为对照组。比较2组年龄、孕前体质量指数、孕次、分娩孕周、新生儿体质量、血压;采用电化学发光法检测2组血清25(OH)D3、sFlt-1、PLGF水平,计算sFlt-1/PLGF;绘制ROC曲线,评估血清25(OH)D3、sFlt-1/PLGF预测孕妇子痫前期的效能。结果 子痫前期组分娩孕周[(38。11±2。01)周]小于对照组[(39。01±1。48)周](t=2。321,P=0。026),新生儿体质量[(3 018。33± 602。82)g]、血清 25(OH)D3 水平[(54。41±16。98)nmol/L]均低于对照组[(3 325。89±480。44)g、(66。58± 23。15)nmol/L](t=2。987,P=0。003;t=2。707,P=0。008),收缩压[(158。98±13。92)mmHg]、舒张压[(94。36± 9。63)mmHg]、sFlt-1/PLGF(25。61±14。95)均高于对照组[(108。14±10。65)mmHg、(66。89±8。37)mmHg、19。78± 12。59](P<0。05),年龄、孕前体质量指数、孕次与对照组比较差异均无统计学意义(P>0。05)。血清25(OH)D3预测孕妇子痫前期的 AUC 为 0。346(95%CI:0。238~0。454,P=0。076),灵敏度为 100。0%,特异度为 0;sFlt-1/PLGF 以 13 为最佳截断值,预测孕妇子痫前期的AUC为0。605(95%CI:0。502~0。707,P=0。006),灵敏度为90。0%,特异度为37。9%;二者联合预测孕妇子痫前期的AUC为0。708(95%CI:0。610~0。815,P<0。001),灵敏度为70。0%,特异度为62。9%。结论 子痫前期孕妇血清25(OH)D3水平降低,sFlt-1/PLGF升高,血清25(OH)D3及sFlt-1/PLGF联合预测子痫前期有较高价值。
Values of soluble fms-like tyrosine kinase-1/placental growth factor and 25-hydroxyvitamin D3 to the prediction of preeclampsia
Objective To observe the changes of serum soluble fms-like tyrosine kinase-1(sFlt-1)/placental growth factor(PLGF)and 25-hydroxyvitamin D3[25(OH)D3]in pregnant women with preeclampsia,and to explore their values to the prediction of preeclampsia.Methods Sixty pregnant women with preeclampsia(preeclampsia group)received regular prenatal examinations and gave birth in Maternal and Child Health Care Hospital Affiliated to Anhui Medical University from January 2020 to September 2022,and another 248 normal pregnant women without pregnancy complications or comorbidities were as controls(control group).The age,pre-pregnancy body mass index,number of pregnancies,gestational age at delivery,body mass of neonates,and blood pressure were compared between two groups.The serum levels of 25(OH)D3,sFlt-1 and PLGF were measured by electrochemiluminescence,and the sFlt-1/PLGF ratio was calculated.ROC curves were plotted to assess the efficiencies of serum 25(OH)D3 and sFlt-1/PLGF on predicting preeclampsia.Results The gestational age at delivery was shorter in preeclampsia group[(38.11± 2.01)weeks]than that in control group[(39.01±1.48)weeks](t=2.321,P=0.026).The body mass of neonates and serum 25(OH)D3 level were lower in preeclampsia group[(3 018.33±602.82)g,(54.41±16.98)nmol/L]than those in control group[(3 325.89±480.44)g,(66.58±23.15)nmol/L](t=2.987,P=0.003;t=2.707,P=0.008).The systolic blood pressure,diastolic blood pressure and sFlt-1/PLGF ratio were higher in preeclampsia group[(158.98± 13.92)mmHg,(94.36±9.63)mmHg,25.61±14.95]than those in control group[(108.14±10.65)mmHg,(66.89±8.37)mmHg,19.78±12.59](P<0.05),and there were no significant differences in the age,pre-pregnancy body mass index and number of pregnancies between two groups(P>0.05).The AUC of serum 25(OH)D3 for predicting preeclampsia was 0.346(95%CI:0.238-0.454,P=0.076),with a sensitivity of 100.0%and a specificity of 0.When the optimal cut-off value of sFlt-1/PLGF was 13,the AUC for predicting preeclampsia was 0.605(95%CI:0.502-0.707,P=0.006),with a sensitivity of 90.0%and a specificity of 37.9%.The AUC of the combination of serum 25(OH)D3 and sFlt-1/PLGF for predicting preeclampsia was 0.708(95%CI:0.610-0.815,P<0.001),with a sensitivity of 70.0%and a specificity of 62.9%.Conclusion The serum 25(OH)D3 level reduces in pregnant women with preeclampsia,while sFlt-1/PLGF increases,and the combination of them two has a high predictive value.

preeclampsia25-hydroxyvitamin D3soluble fms-like tyrosine kinase-1placental growth factor

刘庆、李敬、金永梅、李慧云、蒋晓敏

展开 >

安徽医科大学附属妇幼保健院妇产科,安徽合肥 230000

子痫前期 25-羟维生素D3 可溶性fms样酪氨酸激酶-1 胎盘生长因子

出生人口健康教育部重点实验室开放课题

JK20201

2024

中华实用诊断与治疗杂志
中华预防医学会 河南省人民医院

中华实用诊断与治疗杂志

CSTPCD
影响因子:1.276
ISSN:1674-3474
年,卷(期):2024.38(2)
  • 20